ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
59 hedge funds and large institutions have $24.9M invested in Zynerba Pharmaceuticals, Inc in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 11 closing their positions.
Holders
59
Holders Change
-3
Holders Change %
-4.84%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
17
Reduced
15
Closed
11
Calls
$215K
Puts
$120K
Net Calls
+$95K
Net Calls Change
-$259K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.99M |
2 |
2
Two Sigma Investments
New York
|
$221K |
3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$271K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$858K |
5 |
5
D.E. Shaw & Co
New York
|
$2.48M |